← Back to all clusters

Cluster 11

25 diseases · 81 shared-gene connections
25 Diseases
79 Unique genes
0.317 Avg. similarity score
Collagenopathy Most-connected disease (18 links)
Log in to save this analysis

Save This Analysis

Disease Searched: COL2A1-related spondyloepiphyseal dysplasia Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details · click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) · drag a node to pin it in place · scroll/pinch to zoom.

Member diseases (most connected first ‐ the cluster's core)

Top shared genes (genes linked to 2+ member diseases)

Gene ⇵ Member diseases ⇵ Linked diseases
COL2A1 19 / 25 Avascular necrosis of femoral head, Chondrosarcoma, COL2A1-related spondyloepiphyseal dysplasia, Collagenopathy and 15 more
SS18 3 / 25 Rhegmatogenous retinal detachment, Sarcoma, Synovial sarcoma
BCL2 2 / 25 Chondrosarcoma, Sarcoma
CAPN5 2 / 25 Neovascular inflammatory vitreoretinopathy, Vitreoretinopathy
GNPTAB 2 / 25 Avascular necrosis of femoral head, GNPTAB-mucolipidosis
POMC 2 / 25 Eye disorder, Synovitis
SSX1 2 / 25 Sarcoma, Synovial sarcoma
SSX2 2 / 25 Sarcoma, Synovial sarcoma
TRIM33 2 / 25 Congenital hip dysplasia, Hip dislocation-facial dysmorphism syndrome
UFSP2 2 / 25 Beukes hip dysplasia, Congenital hip dysplasia
What do these columns mean?
Connections in cluster
How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
Significant partners
How many of those links are statistically significant (FDR q < 0.05).
Curated genes
Distinct curated genes linked to that disease in GeDiPNet.
Member diseases (Top shared genes)
How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
Overlap genes (x / y)
x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
Cluster gene count
Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
Fold enrichment
Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
P-value / FDR q-value
Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
Shared genes (Pairs within this cluster)
Number of curated genes the two diseases in that row have in common.
Similarity score (Pairs within this cluster)
Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.

Enriched Pathways (why this cluster is grouped, biologically)

Pathway ⇵ Source ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
Interleukin-4 and Interleukin-13 signaling Reactome 12 / 108 16.9× 4.65e-12 8.90e-10 ✓ sig.
Transcriptional misregulation in cancer KEGG 14 / 198 10.7× 3.36e-11 5.47e-9 ✓ sig.
Cellular senescence KEGG 10 / 157 9.7× 7.27e-8 5.28e-6 ✓ sig.
Human T-cell leukemia virus 1 infection KEGG 11 / 224 7.5× 2.21e-7 1.39e-5 ✓ sig.
Fluid shear stress and atherosclerosis KEGG 9 / 141 9.7× 3.36e-7 2.02e-5 ✓ sig.
Graft-versus-host disease KEGG 6 / 45 20.3× 4.44e-7 2.57e-5 ✓ sig.
Interleukin-10 signaling Reactome 6 / 47 19.4× 5.79e-7 3.22e-5 ✓ sig.
Rheumatoid arthritis KEGG 7 / 95 11.2× 2.82e-6 1.27e-4 ✓ sig.
Herpes simplex virus 1 infection KEGG 9 / 182 7.5× 2.86e-6 1.29e-4 ✓ sig.
African trypanosomiasis KEGG 5 / 37 20.5× 4.01e-6 1.70e-4 ✓ sig.
Inflammatory bowel disease KEGG 6 / 66 13.8× 4.44e-6 1.85e-4 ✓ sig.
Central carbon metabolism in cancer KEGG 6 / 71 12.8× 6.81e-6 2.60e-4 ✓ sig.
Pathways in cancer KEGG 14 / 533 4.0× 8.42e-6 3.09e-4 ✓ sig.
Platinum drug resistance KEGG 6 / 75 12.2× 9.38e-6 3.36e-4 ✓ sig.
p53 signaling pathway KEGG 6 / 75 12.2× 9.38e-6 3.36e-4 ✓ sig.

Enriched GO Terms (Biological Process, a second line of biological evidence)

GO term ⇵ GO ID ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
positive regulation of transcription by RNA polymerase II GO:0045944 26 / 1,208 5.1× 1.71e-12 7.53e-10 ✓ sig.
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand GO:2001240 7 / 37 44.8× 1.71e-10 4.72e-8 ✓ sig.
positive regulation of DNA-templated transcription GO:0045893 19 / 778 5.8× 3.97e-10 9.93e-8 ✓ sig.
vascular endothelial growth factor production GO:0010573 4 / 6 158× 4.41e-9 8.29e-7 ✓ sig.
extrinsic apoptotic signaling pathway in absence of ligand GO:0097192 6 / 36 39.4× 8.28e-9 1.44e-6 ✓ sig.
regulation of gene expression GO:0010468 13 / 402 7.6× 1.27e-8 2.10e-6 ✓ sig.
positive regulation of gene expression GO:0010628 14 / 504 6.6× 2.25e-8 3.46e-6 ✓ sig.
positive regulation of chemokine production GO:0032722 6 / 49 29.0× 5.69e-8 7.60e-6 ✓ sig.
brain development GO:0007420 10 / 244 9.7× 7.84e-8 1.00e-5 ✓ sig.
replicative senescence GO:0090399 4 / 16 59.1× 5.18e-7 4.94e-5 ✓ sig.
positive regulation of neuroinflammatory response GO:0150078 4 / 16 59.1× 5.18e-7 4.94e-5 ✓ sig.
negative regulation of transcription by RNA polymerase II GO:0000122 17 / 1,002 4.0× 7.49e-7 6.70e-5 ✓ sig.
positive regulation of apoptotic process GO:0043065 10 / 326 7.3× 1.13e-6 9.36e-5 ✓ sig.
cellular response to lipopolysaccharide GO:0071222 8 / 187 10.1× 1.23e-6 1.01e-4 ✓ sig.
animal organ morphogenesis GO:0009887 7 / 130 12.7× 1.28e-6 1.04e-4 ✓ sig.

Pairs within this cluster, by significance

Disease A ⇵ Disease B ⇵ Similarity score ⇵ Shared genes ⇵ P-value ⇵ FDR q-value ⇵
Sarcoma Synovial sarcoma 0.088 3 8.97e-9 7.22e-8 ✓ sig.
Eye disorder Synovitis 0.111 2 1.36e-5 6.60e-5 ✓ sig.
Czech dysplasia kniest dysplasia 0.500 1 6.49e-5 2.33e-4 ✓ sig.
kniest dysplasia platyspondylic dysplasia, Torrance type 0.500 1 6.49e-5 2.33e-4 ✓ sig.
Dysspondyloenchondromatosis platyspondylic dysplasia, Torrance type 0.500 1 6.49e-5 2.33e-4 ✓ sig.
Czech dysplasia platyspondylic dysplasia, Torrance type 0.500 1 6.49e-5 2.33e-4 ✓ sig.
Coxa plana Czech dysplasia 0.500 1 6.49e-5 2.33e-4 ✓ sig.
Coxa plana Dysspondyloenchondromatosis 0.500 1 6.49e-5 2.33e-4 ✓ sig.
Coxa plana kniest dysplasia 0.500 1 6.49e-5 2.33e-4 ✓ sig.
Coxa plana spondyloperipheral dysplasia 0.500 1 6.49e-5 2.33e-4 ✓ sig.
Czech dysplasia Dysspondyloenchondromatosis 0.500 1 6.49e-5 2.33e-4 ✓ sig.
Collagenopathy spondyloperipheral dysplasia 0.500 1 6.49e-5 2.33e-4 ✓ sig.
Czech dysplasia spondyloperipheral dysplasia 0.500 1 6.49e-5 2.33e-4 ✓ sig.
Collagenopathy dysplasia of the proximal femoral epiphyses 0.500 1 6.49e-5 2.33e-4 ✓ sig.
Coxa plana dysplasia of the proximal femoral epiphyses 0.500 1 6.49e-5 2.33e-4 ✓ sig.
Czech dysplasia dysplasia of the proximal femoral epiphyses 0.500 1 6.49e-5 2.33e-4 ✓ sig.
dysplasia of the proximal femoral epiphyses Dysspondyloenchondromatosis 0.500 1 6.49e-5 2.33e-4 ✓ sig.
dysplasia of the proximal femoral epiphyses kniest dysplasia 0.500 1 6.49e-5 2.33e-4 ✓ sig.
Dysspondyloenchondromatosis kniest dysplasia 0.500 1 6.49e-5 2.33e-4 ✓ sig.
Dysspondyloenchondromatosis spondyloperipheral dysplasia 0.500 1 6.49e-5 2.33e-4 ✓ sig.
COL2A1-related spondyloepiphyseal dysplasia Coxa plana 0.500 1 6.49e-5 2.33e-4 ✓ sig.
Collagenopathy platyspondylic dysplasia, Torrance type 0.500 1 6.49e-5 2.33e-4 ✓ sig.
Coxa plana platyspondylic dysplasia, Torrance type 0.500 1 6.49e-5 2.33e-4 ✓ sig.
kniest dysplasia spondyloperipheral dysplasia 0.500 1 6.49e-5 2.33e-4 ✓ sig.
kniest dysplasia Stickler syndrome type 1 0.500 1 6.49e-5 2.33e-4 ✓ sig.
Dysspondyloenchondromatosis Stickler syndrome type 1 0.500 1 6.49e-5 2.33e-4 ✓ sig.
Czech dysplasia Stickler syndrome type 1 0.500 1 6.49e-5 2.33e-4 ✓ sig.
Coxa plana Stickler syndrome type 1 0.500 1 6.49e-5 2.33e-4 ✓ sig.
COL2A1-related spondyloepiphyseal dysplasia Collagenopathy 0.500 1 6.49e-5 2.33e-4 ✓ sig.
COL2A1-related spondyloepiphyseal dysplasia Czech dysplasia 0.500 1 6.49e-5 2.33e-4 ✓ sig.
COL2A1-related spondyloepiphyseal dysplasia Dysspondyloenchondromatosis 0.500 1 6.49e-5 2.33e-4 ✓ sig.
COL2A1-related spondyloepiphyseal dysplasia kniest dysplasia 0.500 1 6.49e-5 2.33e-4 ✓ sig.
Collagenopathy Coxa plana 0.500 1 6.49e-5 2.33e-4 ✓ sig.
Collagenopathy Czech dysplasia 0.500 1 6.49e-5 2.33e-4 ✓ sig.
Collagenopathy Dysspondyloenchondromatosis 0.500 1 6.49e-5 2.33e-4 ✓ sig.
Collagenopathy kniest dysplasia 0.500 1 6.49e-5 2.33e-4 ✓ sig.
Collagenopathy Stickler syndrome type 1 0.500 1 6.49e-5 2.33e-4 ✓ sig.
kniest dysplasia Otospondylomegaepiphyseal dysplasia 0.333 1 1.30e-4 3.93e-4 ✓ sig.
Dysspondyloenchondromatosis Otospondylomegaepiphyseal dysplasia 0.333 1 1.30e-4 3.93e-4 ✓ sig.
Czech dysplasia Otospondylomegaepiphyseal dysplasia 0.333 1 1.30e-4 3.93e-4 ✓ sig.
Coxa plana Otospondylomegaepiphyseal dysplasia 0.333 1 1.30e-4 3.93e-4 ✓ sig.
Collagenopathy Otospondylomegaepiphyseal dysplasia 0.333 1 1.30e-4 3.93e-4 ✓ sig.
Avascular necrosis of femoral head Coxa plana 0.250 1 1.95e-4 5.35e-4 ✓ sig.
Neovascular inflammatory vitreoretinopathy Vitreoretinopathy 0.250 1 1.95e-4 5.35e-4 ✓ sig.
Collagenopathy Vitreoretinopathy 0.250 1 1.95e-4 5.35e-4 ✓ sig.
Coxa plana Vitreoretinopathy 0.250 1 1.95e-4 5.35e-4 ✓ sig.
Czech dysplasia Vitreoretinopathy 0.250 1 1.95e-4 5.35e-4 ✓ sig.
Dysspondyloenchondromatosis Vitreoretinopathy 0.250 1 1.95e-4 5.35e-4 ✓ sig.
kniest dysplasia Vitreoretinopathy 0.250 1 1.95e-4 5.35e-4 ✓ sig.
Avascular necrosis of femoral head Collagenopathy 0.250 1 1.95e-4 5.35e-4 ✓ sig.
Avascular necrosis of femoral head Czech dysplasia 0.250 1 1.95e-4 5.35e-4 ✓ sig.
Avascular necrosis of femoral head Dysspondyloenchondromatosis 0.250 1 1.95e-4 5.35e-4 ✓ sig.
Avascular necrosis of femoral head kniest dysplasia 0.250 1 1.95e-4 5.35e-4 ✓ sig.
Avascular necrosis of femoral head GNPTAB-mucolipidosis 0.250 1 1.95e-4 5.35e-4 ✓ sig.
Congenital hip dysplasia Coxa plana 0.167 1 3.25e-4 7.71e-4 ✓ sig.
Beukes hip dysplasia Congenital hip dysplasia 0.167 1 3.25e-4 7.71e-4 ✓ sig.
Collagenopathy Congenital hip dysplasia 0.167 1 3.25e-4 7.71e-4 ✓ sig.
Congenital hip dysplasia Czech dysplasia 0.167 1 3.25e-4 7.71e-4 ✓ sig.
Congenital hip dysplasia kniest dysplasia 0.167 1 3.25e-4 7.71e-4 ✓ sig.
Congenital hip dysplasia Dysspondyloenchondromatosis 0.167 1 3.25e-4 7.71e-4 ✓ sig.
Congenital hip dysplasia Hip dislocation-facial dysmorphism syndrome 0.167 1 3.25e-4 7.71e-4 ✓ sig.
Collagenopathy Rhegmatogenous retinal detachment 0.125 1 4.55e-4 9.73e-4 ✓ sig.
Coxa plana Rhegmatogenous retinal detachment 0.125 1 4.55e-4 9.73e-4 ✓ sig.
Czech dysplasia Rhegmatogenous retinal detachment 0.125 1 4.55e-4 9.73e-4 ✓ sig.
Dysspondyloenchondromatosis Rhegmatogenous retinal detachment 0.125 1 4.55e-4 9.73e-4 ✓ sig.
kniest dysplasia Rhegmatogenous retinal detachment 0.125 1 4.55e-4 9.73e-4 ✓ sig.
Czech dysplasia Maffucci syndrome 0.100 1 5.84e-4 1.16e-3 ✓ sig.
Coxa plana Maffucci syndrome 0.100 1 5.84e-4 1.16e-3 ✓ sig.
Collagenopathy Maffucci syndrome 0.100 1 5.84e-4 1.16e-3 ✓ sig.
Dysspondyloenchondromatosis Synovitis 0.100 1 5.84e-4 1.16e-3 ✓ sig.
Czech dysplasia Synovitis 0.100 1 5.84e-4 1.16e-3 ✓ sig.
Coxa plana Synovitis 0.100 1 5.84e-4 1.16e-3 ✓ sig.
Collagenopathy Synovitis 0.100 1 5.84e-4 1.16e-3 ✓ sig.
Chondrosarcoma Collagenopathy 0.100 1 5.84e-4 1.16e-3 ✓ sig.
Chondrosarcoma Coxa plana 0.100 1 5.84e-4 1.16e-3 ✓ sig.
Chondrosarcoma Czech dysplasia 0.100 1 5.84e-4 1.16e-3 ✓ sig.
Chondrosarcoma Dysspondyloenchondromatosis 0.100 1 5.84e-4 1.16e-3 ✓ sig.
Dysspondyloenchondromatosis Maffucci syndrome 0.100 1 5.84e-4 1.16e-3 ✓ sig.
Coxa plana Eye disorder 0.091 1 6.49e-4 1.24e-3 ✓ sig.
Collagenopathy Eye disorder 0.091 1 6.49e-4 1.24e-3 ✓ sig.
Rhegmatogenous retinal detachment Synovial sarcoma 0.100 1 1.36e-3 2.15e-3 ✓ sig.